Mark J. Murray serves as Executive at Arbutus Biopharma Corp, where they oversee executive responsibilities. Since joining the company, Mark J. Murray has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 28, 2018 involved exercising options for 25,000 shares valued at $33.8K.
Mark J. Murray currently holds 341,396 shares of Arbutus Biopharma Corp (TKMR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark J. Murray has been a net neutral trader of TKMR stock. They have purchased $0 and sold $0 worth of shares.
Mark J. Murray's most recent insider trade was on Nov 28, 2018, when they sold 25,000 shares at $1.35 per share.
Get notified when new Form 4 filings are submitted
| 27,007 |
| $0.35 |
| Discretionary |
| Jun 16, 2016 | ABUS | $12.8K | Exercise | 5,000 | $2.57 | Discretionary |
| Sep 11, 2015 | TKMR | $96.5K | Option Exercise | 219,428 | $0.44 | Discretionary |